„First Line“

Suchergebnisse

3.416 Treffer

• PD-1-Hemmer ist neuer First-line-Standard
  Stiefelhagen, Peter
• Pharmacokinetics of First-Line Anti-Tubercular Drugs
  Mukherjee, Aparna ; Lodha, Rakesh ; Kabra, S. K.
• Simple digital quantum algorithm for symmetric first-order linear hyperbolic systems
  Fillion-Gourdeau, F. ; Lorin, E.
• A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
  Chao, Yee ; Hsieh, Jan-Sing ; Yeh, Hsien-Tang ; Su, Yu-Chieh ; Wu, Cheng-Chung ; Chen, Jen-Shi ; Tai, Cheng-Jeng ; Bai, Li-Yuan ; Yeh, Kun-Huei ; Su, Wu-Chou ; Li, Chung-Pin
• Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
  Gasparini, Giampietro ; Gion, Massimo ; Mariani, Luigi ; Papaldo, Paola ; Crivellari, Diana ; Filippelli, Gianfranco ; Morabito, Alessandro ; Silingardi, Vittorio ; Torino, Francesco ; Spada, Antonella ; Zancan, Matelda ; Sio, Livia De ; Caputo, Antonio ; Cognetti, Francesco ; Lambiase, Antonio ; Amadori, Dino
• High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo
  Dagnra, Anoumou Y. ; Vidal, Nicole ; Mensah, Akovi ; Patassi, Akouda ; Aho, Komi ; Salou, Mounerou ; Monleau, Marjorie ; Prince-David, Mireille ; Singo, Assétina ; Pitche, Palokinam ; Delaporte, Eric ; Peeters, Martine
• Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis
  Colloca, Giuseppe A. ; Venturino, Antonella ; Guarneri, Domenico
• Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial
  Hortobagyi, Gabriel N.
• Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes
  Chin, Ken Lee ; Ofori-Asenso, Richard ; Si, Si ; Hird, Thomas R. ; Magliano, Dianna J. ; Zoungas, Sophia ; Liew, Danny
• Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma – An Evidence Review Group Evaluation of the NICE Single Technology Appraisal
  Thielen, Frederick W. ; Büyükkaramikli, Nasuh C. ; Riemsma, Rob ; Fayter, Debra ; Armstrong, Nigel ; Wei, Ching-Yun ; Huertas Carrera, Vanesa ; Misso, Kate ; Worthy, Gill ; Kleijnen, Jos ; Corro Ramos, Isaac
• Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study
  Clery, Romain ; Grande, Pietro ; Seisen, Thomas ; Gobert, Aurélien ; Duquesne, Igor ; Villers, Arnauld ; Olivier, Jonathan ; Bernhard, Jean-Christophe ; Robert, Grégoire ; Beauval, Jean Baptiste ; Prudhomme, Thomas ; Bruyère, Franck ; Lainé-Caroff, Paul ; Waltregny, David ; Guillonneau, Bertrand ; Panarello, Daniele ; Ruffion, Alain ; Bayser, Hubert De ; Taille, Alexandre de La ; Roupret, Morgan
• Triple-negatives Mammakarzinom: Immuntherapie first-line wirksam
  Stiefelhagen, Peter
• First Tests of a Linear Radiofrequency Quadrupole for the Cooling and Bunching of Radioactive Light Ions
  Ban, G. ; Darius, G. ; Durand, D. ; Delahaye, P. ; Liénard, E. ; Mauger, F. ; Naviliat-Cuncic, O. ; Szerypo, J.
• Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
  Inzaule, Seth C. ; Kityo, Cissy M. ; Siwale, Margaret ; Akanmu, Alani Sulaimon ; Wellington, Maureen ; de Jager, Marleen ; Ive, Prudence ; Mandaliya, Kishor ; Stevens, Wendy ; Boender, T. Sonia ; Ondoa, Pascale ; Sigaloff, Kim C. E. ; Naniche, Denise ; Rinke de Wit, Tobias F. ; Hamers, Raph L.
• Stability Analysis of the First Order Non-linear Impulsive Time Varying Delay Dynamic System on Time Scales
  Shah, Syed Omar ; Zada, Akbar ; Hamza, Alaa E.
• Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
  Venturini, M. ; Bighin, C. ; Monfardini, S. ; Cappuzzo, F. ; Olmeo, N. ; Durando, A. ; Puglisi, F. ; Nicoletto, O. ; Lambiase, A. ; Mastro, L. Del
• Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
  Inoue, Kenichi ; Nakagami, Kazuhiko ; Mizutani, Mitsuhiro ; Hozumi, Yasuo ; Fujiwara, Yasuhiro ; Masuda, Norikazu ; Tsukamoto, Fumine ; Saito, Mitsue ; Miura, Shigeto ; Eguchi, Kenji ; Shinkai, Tetsu ; Ando, Masashi ; Watanabe, Toru ; Masuda, Noriyuki ; Ohashi, Yasuo ; Sano, Muneaki ; Noguchi, Shinzaburo
• Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
  Rose, Tracy L. ; Chism, David D. ; Alva, Ajjai S. ; Deal, Allison M. ; Maygarden, Susan J. ; Whang, Young E. ; Kardos, Jordan ; Drier, Anthony ; Basch, Ethan ; Godley, Paul A. ; Dunn, Mary W. ; Kim, William Y. ; Milowsky, Matthew I.
• Tumor-size responses to first-line is a predictor of overall survival in metastatic colorectal cancer
  Palmieri, Lola-Jade ; Fihri, Amina ; Doat, Solène ; Dubreuil, Olivier ; Manceau, Gilles ; Karoui, Mehdi ; Wagner, Mathilde ; Lucidarme, Olivier ; Bachet, Jean-Baptiste
• A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
  Lu, Jia-huan ; Zuo, Zhi-xiang ; Wang, Wei ; Zhao, Qi ; Qiu, Miao-zhen ; Luo, Hui-yan ; Chen, Zhan-hong ; Mo, Hai-yu ; Wang, Feng ; Yang, Dong-dong ; Wang, Yun ; Wei, Xiao-li ; Wu, Qi-nian ; Ju, Huai-qiang ; Xu, Rui-hua ; Zeng, Zhao-lei